Nicole Calakos | |
---|---|
Born | Boca Raton, Florida, USA |
Spouse(s) | Russell C. Mead, Jr |
Academic background | |
Education | BSc, University of California, Berkeley PhD, MD, Stanford University |
Thesis | Protein interactions within the presynaptic nerve terminal: implications for synaptic vesicle docking and fusion (1995) |
Academic work | |
Institutions | Duke University |
Main interests | Obsessive–compulsive disorder |
Nicole Calakos is an American neuroscientist and neurologist. She is the Lincoln Financial Group Distinguished Professor of Neurobiology at Duke University. She is an elected Member of the American Association for the Advancement of Science,American Society for Clinical Investigation,and National Academy of Medicine for her "pioneering work in optogenetic approaches,and substantial contributions in the area of synaptic plasticity with a focus on striatal circuity of the basal ganglia."
Calakos was born in Boca Raton,Florida to parents Nick and Marien. [1] While in high school,she was encouraged by her biology teacher to attend a University of Florida summer science program. This inspired her to pursue a career in science,specifically scientific medical research. [2] At the age of 16,she was a senior in Boca Raton Community High School and was a semi-finalist in the 1984 National Merit Scholarship competition. [3] Following high school,Calakos enrolled at the University of California,Berkeley before earning her PhD and medical degree at Stanford University. She then completed her internship and residency at the UCSF School of Medicine. [4]
After completing her postdoctoral training at Stanford with Rob Malenka,Calakos became an assistant professor at Duke University in 2005. [5] In this role,she was a member of a research team that developed a new mouse model of Obsessive–compulsive disorder (OCD) by deleting a gene that codes for Sapap3. [6] Her laboratory at Duke became focused on understanding the role of mGluRs in people with OCD through the use of mice. [7] In 2009,Calakos became intrigued in patients with non-familial dystonia and variations of the genes. Her research team found that the DYT1 mutation contributed to childhood-onset dystonia as it was stuck near the cell's nucleus. [8] Calakos's research efforts earned her a Research Incubator Award for 2008–2009 from the Duke Institute for Brain Sciences. [9] She also received one of four 2014 McKnight Memory and Cognitive Disorder Awards from the McKnight Endowment Fund for Neuroscience. [10] In 2015,Calakos became an Harrington Scholar-Innovator to support her project "Novel Targeting of the ER Stress Response Pathway to Treat Movement Disorders of the Nervous System." [2]
Following her promotion to associate professor,Calakos built on her early OCD study and found that overactivity of a single type of receptor for neurotransmitters was the major driver for the abnormal behaviors. [11] This subsequently led to the development of a new cell-based screening test to identify new drug candidates to treat dystonia. [8] Her research contributions were recognised international with an election to the American Society for Clinical Investigation. [4] She was also recognized locally by being named an inaugural Duke Health Scholar. [12] In 2018,Calakos became the clinical principal investigator to study the role of astrocytes in the development of Parkinson's disease. The aim of the project was to identify how genes associated with Parkinson's are expressed by astrocytes. [13]
In 2020,Calakos was appointed the Lincoln Financial Group Distinguished Professor of Neurobiology. [14] She was also elected a Fellow of the American Association for the Advancement of Science for "pioneering work in optogenetic approaches,and substantial contributions in the area of synaptic plasticity with a focus on striatal circuity of the basal ganglia." [15] Two years later,she was also named a National Academy of Medicine for her role as a clinician,scientist,and mentor in the field of movement disorders. [16]
Calakos is married to Russell C. Mead,Jr. [17]
Deep brain stimulation (DBS) is a surgical procedure that implants a neurostimulator and electrodes which sends electrical impulses to specified targets in the brain responsible for movement control. The treatment is designed for a range of movement disorders such as Parkinson's disease,essential tremor,and dystonia,as well as for certain neuropsychiatric conditions like obsessive-compulsive disorder (OCD) and epilepsy. The exact mechanisms of DBS are complex and not entirely clear,but it is known to modify brain activity in a structured way.
Ann Martin Graybiel is an Institute Professor and a faculty member in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology. She is also an investigator at the McGovern Institute for Brain Research. She is an expert on the basal ganglia and the neurophysiology of habit formation,implicit learning,and her work is relevant to Parkinson's disease,Huntington's disease,obsessive–compulsive disorder,substance abuse and other disorders that affect the basal ganglia.
Basal ganglia disease is a group of physical problems that occur when the group of nuclei in the brain known as the basal ganglia fail to properly suppress unwanted movements or to properly prime upper motor neuron circuits to initiate motor function. Research indicates that increased output of the basal ganglia inhibits thalamocortical projection neurons. Proper activation or deactivation of these neurons is an integral component for proper movement. If something causes too much basal ganglia output,then the ventral anterior (VA) and ventral lateral (VL) thalamocortical projection neurons become too inhibited,and one cannot initiate voluntary movement. These disorders are known as hypokinetic disorders. However,a disorder leading to abnormally low output of the basal ganglia leads to reduced inhibition,and thus excitation,of the thalamocortical projection neurons which synapse onto the cortex. This situation leads to an inability to suppress unwanted movements. These disorders are known as hyperkinetic disorders.
Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases,with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.
Joseph Jankovic is an American neurologist and professor at Baylor College of Medicine in Houston,Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.
Guoping Feng is a Chinese-American neuroscientist. He is the Poitras Professor of Neuroscience at the McGovern Institute for Brain Research in the Department of Brain and Cognitive Sciences at MIT and member of the Stanley Center for Psychiatric Research at Broad Institute. He is most notable for studying the synaptic mechanisms underlying psychiatric disease. In addition to developing many genetic-based imaging tools for the study of molecular mechanisms in the brain,he has generated and characterized rodent models of obsessive-compulsive disorder,autism spectrum disorders,and schizophrenia. Feng has also shown that some autism-like behaviors can be corrected in adult mice by manipulating the expression of the SHANK3 gene.
Giovanna Rachele Mallucci is van Geest Professor of Clinical Neurosciences at the University of Cambridge in England and associate director of the UK Dementia Research Institute at the University of Cambridge. She is a specialist in neurodegenerative diseases.
D. James "Jim" Surmeier,an American neuroscientist and physiologist of note,is the Nathan Smith Davis Professor and Chair in the Department of Neuroscience at Northwestern University Feinberg School of Medicine. His research is focused on the cellular physiology and circuit properties of the basal ganglia in health and disease,primarily Parkinson's and Huntington's disease as well as pain.
Ted M. Dawson is an American neurologist and neuroscientist. He is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at Johns Hopkins University School of Medicine. He has joint appointments in the Department of Neurology,Neuroscience and Department of Pharmacology and Molecular Sciences.
Valina L. Dawson is an American neuroscientist who is the director of the Programs in Neuroregeneration and Stem Cells at the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. She has joint appointments in the Department of Neurology,Neuroscience and Physiology. She is a member of the Graduate Program in Cellular and Molecular Medicine and Biochemistry,Cellular and Molecular Biology.
Viviana Grădinaru is a Romanian-American neuroscientist who is a Professor of Neuroscience and Biological Engineering at the California Institute of Technology. She develops neurotechnologies including optogenetics CLARITY tissue clearing,and gene delivery vectors. She has been awarded the Presidential Early Career Award for Scientists and Engineers and the National Institutes of Health Director's Pioneer Award. In 2019 she was a finalist for the Blavatnik Awards for Young Scientists. In 2020 she was awarded a Vilcek Prize for Creative Promise in Biomedical Science by the Vilcek Foundation.
Meaghan Creed is a Canadian neuroscientist and associate professor of anesthesiology at Washington University in St. Louis. Creed has conducted research on understanding and optimizing deep brain stimulation in the basal ganglia for the treatment of neurological and psychiatric disorders. Her work has been recognized at the national and international level by Pfizer,the American Association for the Advancement of Science (AAAS),the Whitehall Foundation,Brain and Behavior Research Foundation and the Rita Allen Foundation.
Camilla Bellone is an Italian neuroscientist and assistant professor in the Department of Basic Neuroscience at the University of Geneva,in Switzerland. Bellone's laboratory explores the molecular mechanisms and neural circuits underlying social behavior and probes how defects at the molecular and circuit level give rise to psychiatric disease states such as Autism Spectrum Disorders.
Ilana B. Witten is an American neuroscientist and professor of psychology and neuroscience at Princeton University. Witten studies the mesolimbic pathway,with a focus on the striatal neural circuit mechanisms driving reward learning and decision making.
Michelle Gray is an American neuroscientist and assistant professor of neurology and neurobiology at the University of Alabama Birmingham. Gray is a researcher in the study of the biological basis of Huntington's disease (HD). In her postdoctoral work,she developed a transgenic mouse line,BACHD,that is now used worldwide in the study of HD. Gray's research now focuses on the role of glial cells in HD. In 2020 Gray was named one of the 100 Inspiring Black Scientists in America by Cell Press. She is also a member of the Hereditary Disease Foundation’s scientific board.
Susanne A. Schneider is a German neurologist at the Ludwig Maximilians-Universität in Munich,Germany who is known for her work in movement disorders.
Mary Kay Lobo is an American psychiatric neuroscientist who is a Professor of Neurobiology at the University of Maryland School of Medicine. Her research considers the molecular mechanisms that underpin drug addiction and depression. She was named a finalist in the 2011 Blavatnik Awards for Young Scientists.
Serena M. Dudek,Ph.D.,is an American neuroscientist known for her work on long-term depression and synaptic plasticity in the CA2 region of the hippocampus.
Christine Klein is a German physician who is a professor of neurology and neurogenetics at the University of Lübeck. Her research considers the molecular genetics of movement disorders. She is a Fellow of the European Academy of Neurology,former President of the German Neurological Society and incoming President of the European Section of the International Parkinson and Movement Disorder Society.